Data / Drug companies / AptaPharma Inc.
AptaPharma Inc.: 30 products in the FDA NDC directory, labeler code 76281
AptaPharma Inc. (labeler code 76281) lists 30 products in the FDA National Drug Code Directory, covering 16 finished drugs by generic name. By type: 29 over the counter drugs, 1 prescription drugs. Its main marketing category is over the counter monograph drugs. The newest product started marketing on May 5, 2026.
SpecStream is the live web data engine for teams and agents. It reads the National Drug Code Directory that FDA publishes, and this page is that reading. Ask for the companies that make a drug, a class or a dosage form, with their headquarters, website and size added from the web, and new listings and discontinued products arrive in your sheet, CRM, Slack or agent as FDA posts them.
- Labeler code
- 76281
- Products in commercial distribution
- 30
- Packages
- 43
- Finished drugs by generic name
- 16
- Prescription products
- 1
- Over the counter products
- 29
- Flagged as original packager
- 29 of 29 products that carry the flag
- Started marketing in the last 12 months
- 6
- Earliest marketing start
- August 21, 2013
- openFDA record search
- api.fda.gov
Products by marketing category
Share of the company's products in commercial distribution.
| Marketing category | Products | Share |
|---|---|---|
| Over the counter monograph drugs | 26 | 86.7% |
| Generic drugs (ANDA) | 3 | 10% |
| New drug applications (NDA) | 1 | 3.3% |
Products by type
| Type | Products | Share |
|---|---|---|
| Over the counter drugs | 29 | 96.7% |
| Prescription drugs | 1 | 3.3% |
Drugs it lists
Finished drugs by generic name, with how many companies list each.
| Drug | Products | Companies listing it |
|---|---|---|
| Acetaminophen, dextromethorphan hbr, phenylephrine hcl | 4 | 45 |
| Acetaminophen | 4 | 214 |
| Bismuth subsalicylate | 4 | 80 |
| Ibuprofen | 3 | 190 |
| Acetaminophen, dextromethorphan hbr, doxylamine succinate | 2 | 40 |
| Dextromethorphan hydrobromide, guaifenesin | 1 | 49 |
| Dextromethorphan hbr, guaifenesin, phenylephrine hcl | 1 | 28 |
| Diphenhydramine hci | 1 | 1 |
| Acetaminophen,dextromethrophan hbr | 1 | 1 |
| Prexxartan | 1 | 1 |
| Acetaminophen, guaifenesin, phenylephrine hcl | 1 | 17 |
| Guaifenesin | 1 | 123 |
| Diphenhydramine hydrochloride | 1 | 127 |
| Acetaminophen,dextromethrophan hbr,doxylamine succinate | 1 | 1 |
| Dextromethorphan hbr, guaifenesin | 1 | 67 |
| Dextromethorphan hydrobromide | 1 | 17 |
Dosage forms
| Dosage form | Products | Share |
|---|---|---|
| Liquid | 18 | 60% |
| Suspension | 7 | 23.3% |
| Capsule, liquid filled | 4 | 13.3% |
| Solution | 1 | 3.3% |
Pharmacologic classes
FDA established pharmacologic classes of its products.
Newest products
By marketing start date.
| Product | Product NDC | Dosage form | Marketing category | Marketing start |
|---|---|---|---|---|
| Prexxartan | 76281-155 | Solution | New drug applications (NDA) | May 5, 2026 |
| Bismuth Subsalicylate Suspension Regular Strength | 76281-557 | Suspension | Over the counter monograph drugs | March 1, 2026 |
| DayTime High Blood Pressure Cold and Flu Relief Liquid filled Softgels | 76281-609 | Capsule, liquid filled | Over the counter monograph drugs | January 1, 2026 |
| Daytime Cold and Flu Relief Liquid Filled Softgels | 76281-604 | Capsule, liquid filled | Over the counter monograph drugs | January 1, 2026 |
| Night Time Cold and Flu relief liquid filled softgels | 76281-603 | Capsule, liquid filled | Over the counter monograph drugs | January 1, 2026 |
| Maximum Strength Tussin DM Liquid filled Softgels | 76281-601 | Capsule, liquid filled | Over the counter monograph drugs | January 1, 2026 |
| CHILDRENS COLD COUGH and SORE THROAT MIXED BERRY | 76281-519 | Liquid | Over the counter monograph drugs | January 30, 2024 |
| SEVERE CONGESTION and COUGH MAX | 76281-517 | Liquid | Over the counter monograph drugs | January 30, 2024 |
| Maximum strength Max Cold and Sinus | 76281-515 | Liquid | Over the counter monograph drugs | January 30, 2024 |
| Childrens mucus relief cough - cherry flavor | 76281-512 | Liquid | Over the counter monograph drugs | January 30, 2024 |
| Stomach Relief, Maximum Strength | 76281-558 | Suspension | Over the counter monograph drugs | September 30, 2020 |
| Tussin Expectorant | 76281-507 | Liquid | Over the counter monograph drugs | September 30, 2020 |
| Childrens Allergy | 76281-505 | Liquid | Over the counter monograph drugs | September 30, 2020 |
| Tussin cf | 76281-504 | Liquid | Over the counter monograph drugs | September 30, 2020 |
| Tussin cough expectorant cough supressant dm | 76281-503 | Liquid | Over the counter monograph drugs | September 30, 2020 |
| Childrens Ibuprofen Oral Suspension Dye free | 76281-128 | Suspension | Generic drugs (ANDA) | September 30, 2020 |
| Childrens Ibuprofen Grape | 76281-126 | Suspension | Generic drugs (ANDA) | September 30, 2020 |
| Childrens Ibuprofen Oral Suspension | 76281-119 | Suspension | Generic drugs (ANDA) | September 30, 2020 |
| Stomach Relief - Maximum Strength | 76281-538 | Liquid | Over the counter monograph drugs | October 1, 2018 |
| Stomach Relief - Regular Strength | 76281-537 | Liquid | Over the counter monograph drugs | October 1, 2018 |
| XL-3 Xtreme | 76281-307 | Liquid | Over the counter monograph drugs | September 1, 2018 |
| XL-3 Day Time | 76281-306 | Liquid | Over the counter monograph drugs | September 1, 2018 |
| Nite-Time COLD/FLU Medicine | 76281-501 | Liquid | Over the counter monograph drugs | March 9, 2018 |
| Nighttime Sleep-Aid Non-Habit Forming | 76281-522 | Liquid | Over the counter monograph drugs | January 1, 2018 |
| Day-Time Cold/Flu Relief | 76281-506 | Liquid | Over the counter monograph drugs | January 1, 2018 |
Updated November 6, 2026. Read from US Food and Drug Administration, National Drug Code Directory (openFDA). CC0 1.0 public domain dedication (openFDA). Counts are products in the FDA National Drug Code Directory on November 6, 2026: 138,262 products in commercial distribution, meaning without a marketing end date in the past. A company is a labeler code; one company can hold several codes, and the directory carries no address. Inclusion in the directory is not FDA approval, and the marketing category says under which kind of application or rule a product is sold. This page uses openFDA data and is not endorsed or certified by FDA. Free to reuse with credit to SpecStream under CC BY 4.0. Spot a wrong value? Write to [email protected] with the link to this page.